Objective: To determine the prevalence of acute coronary syndromes among type 2 diabetic patients presenting to Accident and Emergency department. Design: Prospective cross-sectional study. Setting: Kenyatta National Hospital, a tertiary teaching and referral hospital. Subjects: Type 2 diabetic patients with ischaemic electrocardiograms (ECG). Main outcome measures: Demographics, clinical symptoms, cardiovascular status and risk factors -central obesity, hypertension, dyslipidaemia, smoking. Results: From 12,307 accident and emergency attendees, 400 ( 33%) diabetics aged >30 years were screened with a resting ECG and 95 (24%) with ischaemic ECG were recruited; age range 41-87 years, 60% were male; diabetes duration ranged 0-30 years with 8.4% being newly diagnosed. The commonest enrolling ECG feature was nonspecific ST-T changes. The commonest presenting complaint were fatigue and dyspnoea. Majority had three coronary artery disease (CAD) risk factors: obesity 86%, elevated LDL 73% and hypertension 60%. Therapy in use was OHA 43%, insulin 42%, insulin and OHA 1%; prophylactic aspirin 14.7% and statins 8.4%. Thirty four (35.8%) were classified as acute coronary syndrome (ACS); 29 ( 30.5%) acute myocardial infarction (ACS-AMI) and five (5.2%) unstable angina (ACS-UA). Majority (79.4%) of the ACS presented more than six hours after symptom onset and majority had features of acute left ventricular failure. Conclusions: Acute coronary syndrome accounted for 35% of the morbidity in type 2 diabetics with ischaemic ECG's presenting to KNH accident and emergency department; patients presented late and 80% were not on CAD prophylactic therapy.
INTRODUCTION
The global number of individuals with diabetes is projected to increase markedly from 171 million (2.8% of the world's population) in 2000 to 366 million (6.5%) in 2030; 298 million of whom, will live in developing countries (1) . Cardiovascular disease, with its attendant morbidity and mortality, particularly in the diabetic population, is on the rise in the developing countries (2) with mortality expected to increase from an estimated 9 million in 1990 to 19 million by 2020 (3) .
Coronary artery disease (CAD) is a major cause of morbidity and mortality amongst patients with diabetes mellitus. Several studies have shown that compared to non-diabetics, diabetics have a higher prevalence of CAD, a greater extent of coronary ischaemia, and are more likely to have acute myocardial infarction (AMI), and silent myocardial ischaemia (4 -6) .
Coronary artery disease is a growing epidemic on the African continent, on account of the increasing prevalence of the classical risk factors for CAD, with a regularly reported concurrence of multiple risk factors in the same individual (7) . In the INTERHEART Africa study (8) , history of smoking, diabetes, hypertension, abdominal obesity, and ratio of apolipoprotein B to apolipoprotein A-1 provided for a population attributable risk of 89.2% for AMI. Non-specific ST-T wave ECG changes has also been shown to have CAD prediction power and can be considered as a risk factor (9) .
In observational studies of CAD in diabetes, incidence rates of AMI have varied widely mainly as a function of ethnic background, inclusion criteria, definition of end points, and duration of follow-up (10) (11) (12) . There is limited local data on the prevalence and presenting characteristics of ACS amongst the diabetics in our population.
Consequently, the aim of this study was to determine the prevalence and presenting characteristics of acute coronary syndromes amongst type 2 diabetics with ischaemic ECG's.
MATERIALS AND METHODS
During the period of July 2007 to October 2007 all type 2 diabetic patients, with a prior chart diagnosis/treatment or A&E newly diagnosed and aged >30 years, presenting to the Kenyatta National Hospital and Emergency Department (KNH A&E) with medical complaints were screened with a 12 lead resting ECG using a standardised portable machine. Those with ECG features of ischaemia were consecutively recruited and underwent a thorough clinical evaluation including weight, waist and hip circumferences and blood drawn for measurement of serial serum Troponin I and fasting lipid levels.
Ischaemia ECG features were defined as follows: Abnormal Q waves: any Q waves in leads V1 to V3 or Q wave > 30m sec in leads I, II, aVL, aVF, or V4 -V6; present in any two contiguous leads and > 1 mm in depth. ST elevation: 1 mm from the baseline measured at 0.08 seconds from the J point, in at least two contiguous precordial leads or in at least two adjacent limb leads. ST depression not associated with ventricular hypertrophy: horizontal, down sloping or up sloping depression at >1 mm from the baseline measured at 0.08 seconds from the J point. T wave inversion not associated with ventricular hypertrophy and Left Bundle Branch Block by standard conventional criteria (13) .
Patients were classified as hypertensive on basis of a chart diagnosis or treatment for hypertension. Newly diagnosed patients were diagnosed on the basis of JNC 7 criteria by the attending A&E physician. Cigarette smoking status was classified as either current smoker: last smoked within the past one year or non -smoker: last smoked more than a year ago or had never smoked. A positive family history of CAD was defined as CAD in a first degree relative occurring before age of 60 years (14) . Waist circumference was measured in cm, in the horizontal plane, at the level of the narrowest part of the torso between the lowest rib and the top of the pelvis, as seen from the anterior view, at the end of a normal expiration (15) . A measured value of > 102cm in males and > 88 cm in females was classified as Central obesity as defined by NCEP/ATPIII (16) . The hip circumference was measured in centimeters, as the maximum circumference at the level of the greater trochanters in the horizontal plane (17) . The Waist Hip Ratio was calculated as the ratio of the former to the latter and defined by WHO criteria as abnormal if the ratio was >0.90 in males and >0.85 in females (18) .
Two mililiters of blood was drawn for measurement of serum Troponin I and if the initial level was normal, a second sample was drawn 8 hours later. The samples were assayed by a dedicated study technician at the KNH laboratory with the Minividas Troponin I kit by HASS Ltd. Serum Troponin I levels > 0.01 ng/ml were considered elevated and therefore diagnostic of an acute myocardial infarction, representing the 99th percentile value for the kit utilised (13) . Two mls of blood was drawn after an 8 hour fast for fasting lipid levels. The samples were assayed by a dedicated study technician at the Department of Internal Medicine laboratory, University of Nairobi with the Human kits by HUMAN Ltd. According to the NCEP/ATP III guidelines (16), the following levels were considered abnormal: HDL-C < 1.03 mmol/I (for both genders); Triglycerides > 1.7 mmolll and LDL-C > 1.8 mmol/l.
Study patients were classified as ACS or Non-ACS on basis of the following criteria; Acute myocardial infarction: elevated serum Troponin I; unstable angina: normal serum Troponin I with concurrent angina; Non-ACS: normal serum Troponin I without concurrent angina or angina equivalent dyspnoea.
The study was approved by the KNH ethics committee. Data was analysed with SPSS version 15.0 software. Continuous data was analysed into means and categorical data were analysed into percentages with the corresponding 95% confidence intervals. Prevalence rates were calculated similarly. Statistical significance was defined as a two tailed p-value of less than or equal to 0.05.
RESULTS
Over a four month period between 1st July 2007 to 31st October 2007,12,307 medical case patients were attended to at Kenyatta National Hospital Accident and Emergency Department (KNH A&E), 400 (33%) of whom were diabetics aged over 30 years. The latter group comprised our study target population and were consecutively screened with an index resting 12 lead ECG; 95 (24%) were classified as ischaemic ECG and were recruited. Over the study recruitment period the numbers screened and proportion recruited on a weekly basis did not vary considerably; with a weekly average of 22 individuals screened and 22% recruited. (Figure 1 ). Age ranged from 41-87 years with a mean age of 63.3 years; 60% were male; 56% were either retired of unemployed; 58% had attained primary level of education whereas only 42% had attained secondary or above level of education. Minority of the patients were newly diagnosed diabetics (8.4%); diabetic disease duration ranged from 0-30 years with a mean of 11 years. The commonest A&E presenting complaint was exertional dyspnoea in 51.6 % ; 30.5% were in NYHA Class III/IV; rest angina 16.8%, epigastric pain 12.6% and cerebrovascular accident 4.2% ( Figure 2 ). All patients had at least one other cardiovascular risk factor, with the majority having more than three factors; Obesity by WHR 86%, elevated LDL 73% obesity by waist circumference (WC) 62% and hypertension 60%. Cigarette smoking was infrequent at 8.4% as was prior MI and family history both at 1%. ( Figure 3 ). Median and range lipid values were total cholesterol 4.5 (1.4-10.5) mmol/I, LDL-C 2.4 (0.5-9.4) mmol/l, HDL 0.9 ( 0.1-2.4) mmol/I and triglycerides 1.1 ( 0.2-7.7) mmol/1. Dyslipidaemia was documented in 95%; 73% elevated LDL-C, 54.7% depressed HDL and 30% elevated triglycerides (TGs); 51.6% had only one lipid abnormality; 36.8% had two abnormalities while 6.3% had all three lipid abnormalities ( Figure 5 ). Most women (97%) were postmenopausal and all smokers were male. Women were more likely to be classified as obese on basis of the WC (male 43.9%; female 89.5%, p -0.001); whereas on the basis of WHR obesity was equally distributed among the genders. 
Figure 5 Occurrence of combinations of elevated LDLC/low HDLC and elevated triglycerides
There was no statistically significant difference between the male and female patients with regard to the prevalence of hypertension (p = 0.4), central obesity as defined by waist-hip ratio (p = 0.6) and elevated LDL -Cholesterol (p = 0.6). Anti-diabetic therapy utilised prior to A&E presentation included oral hypoglycaemic agents (OHA) in 43%, insulin 42%, insulin and OHA 1% and dietary control in 5.3%. Only 14.7% and 8A% of the patients in the study population were on aspirin and statins therapy respectively.
On the basis of clinical presentation and Troponin assays 34 (35.8%) participants were classified as having an acute coronary syndrome (ACS); 29 (30.5%) acute myocardial infarction (ACS-AMI), five (5.2%) unstable angina (ACS-UA) and 61 (64.2%) as non-ACS presentations. (Figure 4) .The most common symptoms amongst the patients with ACS were breathing difficulty and fatigue; 47% presented with typical angina whereas 52.9% had atypical symptoms. Majority (79.4%) of ACS patients presented to the A&E six hours or more after onset of symptoms; the mean duration of symptoms being 5.5 days and majority had features of acute left ventricular failure ( Figure 6 ).
Figure 6 Cardiovascular status of patients with acute myocordial infarction
No statistically significant difference was evident between patients with and without acute coronary syndromes, in terms of age, gender, 
DISCUSSION
Our findings demonstrate that type 2 diabetics comprise 3% of all medical A&E attendees, over a six month period, at this tertiary referral facility that also serves as a primary care emergency facility for the majority of the population of the city of Nairobi and its environs, with an estimated population of 3-4 million inhabitants. This is a significant proportion and is consistent with records at this facility and we believe the study reflects the rising prevalence of type 2 diabetes in our urban and peri-urban populations, for which no comprehensive data exists. By design we opted for the age entry criteria of 30 years to predominantly capture a sample of type 2 diabetes, which we have reason to believe was indeed the case.
A quarter of these diabetic patients demonstrated study designated ischaemic changes in their resting EGG; with the majority showing non-specific ST-T wave changes. A minority showed ECG evidence of on-going ischaemia, with ST elevation and presumably new LBBB pattern; and atrial fibrillation. This high frequency of ischaemic ECG changes is compatible with the high cardiovascular risk profile of the study sample, as demonstrated by their demographics, diabetic vascular age and high prevalence of multiple cardiovascular risk factors. We selected non-specific ischaemic ECG changes as a marker for high CAD risk patient group.
A similar high risk profile has been demonstrated in recent studies on type 2 diabetics attending the institution's out-patient diabetic clinics (19) . Despite being at high CHD risk, inclusive of significant dyslipidaemia, and the practice guideline recommendations of intensive risk reduction treatment for such patients, the use of statins and mandatory anti-platelet therapy was abysmal. The reasons for this are probably multi-factorial and warrant further study and urgent intervention, in particular regard to the inexpensive and readily accessible acetylsalicylic acid (ASA) therapy.
Consequently a third of these patients were classified as having an ongoing acute coronary syndrome (AGS), on the basis of clinical profile and elevated Troponin assay. This proportion contrast sharply with departmental records, reviewed and compiled as part of the planning stage of this study, which suggested a 7.3% four month period prevalence (July-October 2006) of AMI in type 2 diabetic attending the A&E. Despite acknowledging the potential incompleteness of routine data, this discrepancy in prevalence suggests that up to two thirds of such patients are being miss-classified as non-ACS at A&E presentation evaluation, leading to potential delayed life saving interventions and inappropriate triage; all of which does not portend well for favorable outcomes. An important observation is the late and atypical mode of presentation of our ACS in diabetics. Possible reasons for this include the DM associated sensory neuropathy, failure by patients and primary health care workers to recognise the implication of symptoms and inaccessibility to health care; these factors can be potentially overcome by comprehensive health education. Our data is limited by the potential for type 2 diabetes misclassification bias and tertiary facility referral bias. The performance of C-peptide and IIlet cell antibodies studies were unavailable to minimise the latter however, the age range of our sample of 40-87 years and the mean duration of diabetes of 11 years, we believe make the contribution of this bias as nominal. None of our study cases were hospital transfers however the poor haemodynamic profile of cases should be seen in the light of this inherent referral bias.
In conclusion we have demonstrated that ACS are not infrequent among type 2 diabetics presenting to our A&E department and that we need to increase vigilance among our staff by imploring a high index of suspicion, given the high risk profile and atypical and varied presentation profile of our patients. We recommend that all diabetics attending our A&E should undergo a screening ECG evaluation as part of their workup along with a myocardial cell death marker depending on the clinical profile.
